-
Signature
-
/s/ Ben Hohl, by power of attorney
-
Issuer symbol
-
ELVN
-
Transactions as of
-
23 Sep 2025
-
Net transactions value
-
-$56,084
-
Form type
-
4
-
Filing time
-
25 Sep 2025, 19:42:57 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Kintz Samuel |
PRESIDENT AND CEO, Director |
C/O ENLIVEN THERAPEUTICS, INC., 6200 LOOKOUT ROAD, BOULDER |
/s/ Ben Hohl, by power of attorney |
25 Sep 2025 |
0001967168 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ELVN |
Common Stock |
Sale |
$56,084 |
-2,800 |
-0.3% |
$20.03 |
919,092 |
23 Sep 2025 |
See footnote |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: